CalciMedica (CALC) Cash from Operations (2019 - 2026)
CalciMedica's (CALC) quarterly Cash from Operations came in at 4856000.0 in Q1 2026, little changed YoY from 4834197.55 in Q1 2025, and little changed on a QoQ basis from 4852000.0 in Q4 2025.
CalciMedica (CALC) Cash from Operations (2019 - 2026) Analysis & Trends
CalciMedica (CALC) has 8 years of Cash from Operations data on file, last reported at 4856000.0 in Q1 2026.
- Quarterly Cash from Operations changed 0.45% year-over-year to 4856000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 21156000.0 (up 0.72% YoY) and the FY2025 annual result came in at 21178000.0, changed 0.15% from the prior year.
- Cash from Operations steadied at 4856000.0 in Q1 2026, from 4852000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 1826000.0 in Q3 2022 to a low of 12192000.0 in Q2 2023.
- A 5-year average of 4980411.76 and a median of 4778000.0 in 2025 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2022 — Cash from Operations soared 71.52% — and 2023, when it slumped 450.18%.
- Tracing CALC's Cash from Operations over 5 years: stood at 4089000.0 in 2022, then rose by 11.67% to 3612000.0 in 2023, then plunged by 37.65% to 4972000.0 in 2024, then grew by 2.41% to 4852000.0 in 2025, then decreased by 0.08% to 4856000.0 in 2026.
- The last three Cash from Operations figures came in at 4856000.0 (Q1 2026), 4852000.0 (Q4 2025), and 4778000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 326.72 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 360.27 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -88.83 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 728.46 Mn |
| 10 | CalciMedica | 9.80 Mn | -8.82 Mn | - | -4.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.62 Mn |
| Jun 30, 2026 | -4.62 Mn |
| Mar 31, 2026 | -4.86 Mn |
| Mar 31, 2026 | -4.86 Mn |
| Dec 31, 2025 | -4.85 Mn |
| Dec 31, 2025 | -4.85 Mn |
| Sep 30, 2025 | -4.78 Mn |
| Sep 30, 2025 | -4.78 Mn |
| Jun 30, 2025 | -6.67 Mn |
| Jun 30, 2025 | -6.67 Mn |
| Mar 31, 2025 | -4.88 Mn |
| Mar 31, 2025 | -4.88 Mn |
| Dec 31, 2024 | -4.97 Mn |
| Dec 31, 2024 | -4.97 Mn |
| Sep 30, 2024 | -4.67 Mn |
| Sep 30, 2024 | -4.67 Mn |
| Jun 30, 2024 | -6.79 Mn |
| Jun 30, 2024 | -6.79 Mn |
| Mar 31, 2024 | -4.72 Mn |
| Mar 31, 2024 | -4.72 Mn |